4-Aminophenol sulfate | CAS:63084-98-0

We serve 4-Aminophenol sulfate CAS:63084-98-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Aminophenol sulfate

Chemical Name:4-Aminophenol sulfate
CAS.NO:63084-98-0
Synonyms:P-AMINOPHENOL SULFATE
4-AMINOPHENOL-ORTHO-SULPHATE;
Molecular Formula:C6H7NO4S
Molecular Weight:189.18900
 
Physical and Chemical Properties:
Melting point:160oC;
Boiling point:282oC;
Flash point:124.3oC;
 
Specification:
Appearance:White crystalline powder
Purity(HPLC):≥99.0%
Ash:≤1.0%
Loss on drying:≤0.2%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 4-Aminophenol sulfate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-AMINOPHENOL-ORTHO-SULPHATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-AMINOPHENOL-ORTHO-SULPHATE Use and application,4-AMINOPHENOL-ORTHO-SULPHATE technical grade,usp/ep/jp grade.


Related News: Dr Maria Van Kerkhove, of the WHO’s emerging diseases unit, says it is important that you keep up basic hand and respiratory hygiene, such as washing your hands with soap and water and sneezing into your elbow or a tissue.Benzoyl chloride manufacturer Dr Maria Van Kerkhove, of the WHO’s emerging diseases unit, says it is important that you keep up basic hand and respiratory hygiene, such as washing your hands with soap and water and sneezing into your elbow or a tissue.2-Bromo-5-nitrobenzotrifluoride supplier Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.L-Menthyl glyoxylate hydrate vendor Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.